-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Infigratinib Phosphate in Achondroplasia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Infigratinib Phosphate in Achondroplasia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Infigratinib Phosphate in Achondroplasia Drug Details: Infigratinib phosphate (Truseltiq) is an...
-
Product Insights
Achondroplasia – Drugs In Development, 2023
Global Markets Direct’s, ‘Achondroplasia - Drugs In Development, 2023’, provides an overview of the Achondroplasia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Achondroplasia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Guizhou QED – Wudang-Changshun Expressway – Guizhou
Equip yourself with the essential tools needed to make informed and profitable decisions with our Guizhou QED - Wudang-Changshun Expressway - Guizhou report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the Guizhou...
-
Product Insights
Toxicology Tests – OraSure Technologies Inc – QED
GlobalData, the industry analysis specialist, has released its latest report: Toxicology Tests - OraSure Technologies Inc - QED. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the...
-
Company Profile
Graco Inc – Company Profile
Graco Inc (Graco) is a provider of fluid handling systems and components. It designs, develops, manufactures and sells equipment that pumps, mixes, meters, dispenses and sprays a wide variety of fluids and semi-solids. The company provides technology and expertise for the management of fluids and coatings in industrial and commercial applications. It serves construction, manufacturing, processing and maintenance industries. It markets its products under the brand names of Airlessco, ASM, RentalPro, Smith, Sharpe, Gema, High Pressure Equipment, QED Environmental Systems...
Add to Basket -
Product Insights
Toxicology Tests, ORASURE TECHNOLOGIES INC, QED, pricing in the Brazil, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Toxicology Tests, ORASURE TECHNOLOGIES INC, QED, pricing in the Brazil, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is...
-
Product Insights
Toxicology Tests, ORASURE TECHNOLOGIES INC, QED, pricing in the Australia, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Toxicology Tests, ORASURE TECHNOLOGIES INC, QED, pricing in the Australia, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is...
-
Product Insights
Toxicology Tests, ORASURE TECHNOLOGIES INC, QED, pricing in the Austria, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Toxicology Tests, ORASURE TECHNOLOGIES INC, QED, pricing in the Austria, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is...
-
Product Insights
Toxicology Tests, ORASURE TECHNOLOGIES INC, QED, pricing in the Belgium, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Toxicology Tests, ORASURE TECHNOLOGIES INC, QED, pricing in the Belgium, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is...
-
Product Insights
Toxicology Tests, ORASURE TECHNOLOGIES INC, QED, pricing in the Canada, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Toxicology Tests, ORASURE TECHNOLOGIES INC, QED, pricing in the Canada, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is...